Stimulation of DNA synthesis in untransformed cells by the antiviral and antitumoral compounds tricyclodecan-9-yl-xanthogenate (D609)

Biochemical Pharmacology

Volumn 55, Issue 6, 1998, Pages 915-918

  Kiss, Zoltan ^a   Crilly, Karan S ^a   Chung, Taeowan ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Yeungnam University   (South Korea)

Author keywords

Compound D609; DNA synthesis; Fibroblasts; MAP kinase

Indexed keywords

ADENOSINE TRIPHOSPHATE; INSULIN; PHOSPHORYLCHOLINE; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE; TRICYCLODECAN 9 YL XANTHOGENATE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; MITOGENESIS; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL;

3T3 CELLS; ADENOSINE TRIPHOSPHATE; ANIMALS; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; BRIDGED COMPOUNDS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL LINE, TRANSFORMED; DNA; DRUG SYNERGISM; INSULIN; MICE; PHOSPHORYLCHOLINE; STIMULATION, CHEMICAL; THIONES;

EID: 0032520745     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00596-0     Document Type: Article

References (21)

1. Sauer R, Amtmann E, Melber K, Knapp A, Müller K, Hummel K, Scherm A. DNA and RNA virus species are inhibited by xanthates, a class of antiviral compounds with unique properties. Proc Natl Acad Sci USA. 81:1984;3263-3267.
2. Mellert W, Amtmann E, Erfle V, Sauer G. Inhibition of HIV-1 replication by an antiviral xanthate compound in vitro. AIDS Res Hum Retroviruses. 4:1988;71-81.
3. Amtmann E, Müller K, Knapp A, Sauer G. Reversion of bovine papillomavirus-induced transformation and immortalization by a xanthate compound. Exp Cell Res. 161:1985;541-550.
4. Fürstenberger G, Amtmann E, Marks F, Sauer G. Tumor prevention by a xanthate compound in experimental mouse-skin tumorigenesis. Int J Cancer. 43:1989;508-512.
5. Müller-Decker K. Interruption of TPA-induced signals by an antiviral and antitumoral xanthate compound Inhibition of a phospholipase C-type reaction . Biochem Biophys Res Commun. 162:1989;198-205.
6. Müller-Decker K, Doppler C, Amtmann E, Sauer G. Interruption of growth signal transduction by an antiviral and antitumoral xanthate compound. Exp Cell Res. 177:1988;295-302.
7. Gratas C, Powis G. Inhibition of phospholipase D by agents that inhibit cell growth. Anticancer Res. 13:1993;1239-1244.
8. Kiss Z, Tomono M. Compound D609 inhibits phorbol ester-stimulated phospholipase D activity and phospholipase C-mediated phosphatidylethanolamine hydrolysis. Biochim Biophys Acta. 1259:1995;105-108.
9. Schütze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Krönke M. TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell. 71:1992;765-776.
10. Halstead J, Kemp K, Ignotz RA. Evidence for involvement of phosphatidylcholine-phospholipase C and protein kinase C in transforming growth factor-β signaling. J Biol Chem. 270:1995;13600-13603.
11. Cifone MG, Roncaioli P, De Maria R, Camarda G, Santoni A, Ruberti G, Testi R. Multiple pathways originated at the Fas/APO-1 (CD95) receptor Sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal . EMBO J. 14:1995;5859-5868.
12. Pastorino JG, Simbula G, Yamamoto K, Glascott PA Jr, Rothman RJ, Farber JL. The cytotoxicity of tumor necrosis factor depends on induction of the mitochondrial permeability transition. J Biol Chem. 271:1996;29792-29798.
13. Cai H, Erhardt P, Troppmair J, Diaz-Meco MT, Sithanandam G, Rapp UR, Moscat J, Cooper GM. Hydrolysis of phosphatidylcholine couples Ras to activation of Raf protein kinase during mitogenic signal transduction. Mol Cell Biol. 13:1993;7645-7651.
14. Belka C, Wiegmann K, Adam D, Holland R, Neuloh M, Herrmann F, Krönke M, Brach MA. Tumor necrosis factor (TNF)-α activates c-raf-1 kinase via the p55 TNF receptor engaging neutral sphingomyelinase. EMBO J. 14:1995;1156-1165.
15. Wartmann M, Hofer P, Turowski P, Saltiel AR, Hynes NE. Negative modulation of membrane localization of the Raf-1 protein kinase by hyperphosphorylation. J Biol Chem. 272:1997;3915-3923.
16. Walter M, Reinecke H, Gerdes U, Nofer JR, Höbbel G, Seedorf U, Assmann G. Defective regulation of phosphatidycholine-specific phospholipases C and D in a kindred with Tangier disease. Evidence for the involvement of phosphatidylcholine breakdown in HDL-mediated cholestrol efflux mechanisms. J Clin Invest. 98:1996;2315-2323.
17. 3 stimulates multiple signaling pathways in human skin fibroblasts. Arterioscler Thromb Vasc Biol. 15:1995;1975-1986.
18. Bertrand PP, Galligan JJ. Signal-transduction pathways causing slow synaptic excitation in guinea pig myenteric AH neurons. Am J Physiol. 269:1995;G710-G720.
19. Chung T, Crilly KS, Anderson WH, Mukherjee JJ, Kiss Z. ATP-dependent choline phosphate-induced mitogenesis in fibroblasts involves activation of pp70 S6 kinase and phosphatidylinositol 3′-kinase through an extracellular site Synergistic mitogenic effects of choline phosphate and sphingosine-1-phosphate . J Biol Chem. 272:1997;3064-3072.
20. Chung J, Kuo CJ, Crabtree GR, Blenis J. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kD S6 protein kinases. Cell. 69:1992;1227-1236.
21. Chou MM, Blenis J. The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Rac1. Cell. 85:1996;573-583.